Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Cash from Operations (2022 - 2025)

Historic Cash from Operations for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $1.0 billion.

  • GE HealthCare Technologies' Cash from Operations rose 1500.55% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year increase of 163.68%. This contributed to the annual value of $2.0 billion for FY2025, which is 163.68% up from last year.
  • Latest data reveals that GE HealthCare Technologies reported Cash from Operations of $1.0 billion as of Q4 2025, which was up 1500.55% from $593.0 million recorded in Q3 2025.
  • GE HealthCare Technologies' Cash from Operations' 5-year high stood at $1.1 billion during Q4 2022, with a 5-year trough of -$119.0 million in Q2 2024.
  • Its 4-year average for Cash from Operations is $511.1 million, with a median of $530.5 million in 2022.
  • Per our database at Business Quant, GE HealthCare Technologies' Cash from Operations tumbled by 25263.16% in 2023 and then skyrocketed by 17899.16% in 2025.
  • Quarter analysis of 4 years shows GE HealthCare Technologies' Cash from Operations stood at $1.1 billion in 2022, then dropped by 1.22% to $1.0 billion in 2023, then fell by 13.05% to $913.0 million in 2024, then increased by 15.01% to $1.0 billion in 2025.
  • Its Cash from Operations was $1.0 billion in Q4 2025, compared to $593.0 million in Q3 2025 and $94.0 million in Q2 2025.